A Multicenter Study Based on Multi-omics Analysis to Predict the Early Prognosis and Recurrence Risk of Acute Ischemic Stroke

Recruiting now

Conditions studied: Ischemic Stroke, Acute

In brief

Through a multicenter prospective AIS cohort study, we analyze the potential association of human proteome, microbiome and metabolome alterations with AIS prognosis, searching for key proteins, differential organisms and metabolites, combining experimental data at multiple molecular levels with computational models, and establishing early prediction models through machine learning-based prediction algorithms. While closely tracking the recurrence of stroke in AIS patients, we evaluate the predictive value of human proteome, microbiome and metabolites for stroke recurrence through a nested case-control study, which provides key reference information for exploring the unknown residual risk of AIS recurrence.

Key facts

Study ID

NCT06584565

Run by

Nanfang Hospital, Southern Medical University

People needed

400

Starts

2024-01-30

Expected to finish

2028-12-31

Last updated by the study team

2024-09-05

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Meet the diagnostic criteria of AIS according to the Chinese Guidelines for the Diagnosis and Treatment of Acute Ischemic Stroke 2018
• Aged 18 to 75 years old
• Stroke within 7 days of onset
• Sign informed consent, provide relevant medical history information and provide biological specimens

You may not qualify if…

• Severe impairment of consciousness (awareness score of NIHSS>1)
• History of stroke within 12 months
• Severe systemic disease including malignancy
• ALT or AST> 2 times the upper limit of normal or severe liver disease
• creatinine > 1.5 times the upper limit of normal or severe kidney disease
• History of long-term drinking, drug use, and chemical poisoning (e.g., pesticide poisoning); Note: Long-term alcohol consumption, usually more than 5 years, over 40 g/day of alcohol for men and 20 g/day for women, or a history of heavy alcohol consumption within 2 weeks, over 80 g/day of alcohol
• History of intestinal tumors, irritable bowel syndrome or inflammatory bowel disease or confirmed in the hospital
• Unable to collect a stool specimen within 4 days of admission
• Assessed to be unsuitable for participation in this study by the investigator

Where it is running

• Nanfang Hospital,Southern Medical University — Guangzhou, Guangdong, China (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.